AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
EMAP II Inhibitors to Treat Cardiovascular Disease
Detailed Technology Description
TechnologySummary: Targets Endothelial Monocyte Activating Polypeptide (EMAP II) to promote cardiac tissue regeneration in patients suffering from myocardial infarction or pulmonary hypertension.
Countries
United States
Application No.
7,537,757
Country/Region
USA
For more information, please click Here
